Beliefs About Medicines and Adherence to Treatment in Turkish Patients with Inflammatory Bowel Disease

Background: Although studies are investigating the perception and beliefs about treatment and adherence to treatment in different societies related to inflammatory bowel disease, there are no studies on this subject in Turkish people with different sociocultural structures. In our study, we aimed to evaluate the beliefs about treatment and its effect on adherence to treatment in the Turkish population with inflammatory bowel disease. Methods: In the study, the “Medication Adherence Report Scale” and “Beliefs about Medicines Scale” scales were used to evaluate the treatment compliance and perception and beliefs about treatment. Characteristics that could affect treatment compliance were evaluated by statistical analysis. Results: A total of 253 patients, 167 with ulcerative colitis and 86 with Crohn’s disease, were included in the study. The non-adherence rate to the treatment was found as 41.9% in ulcerative colitis and 24.4% in Crohn’s disease (P = .006). Intentional (29.3% in ulcerative colitis and 16.3% in Crohn’s disease [P = .031] and unintentional non-adherence to treatment (28.1% in ulcerative colitis, 16.3% in Crohn’s disease [P = .037] were significantly higher in ulcerative colitis than in Crohn’s disease. Female gender (odds ratio = 2.59, P = .005), low education level (odds ratio = 4.8, P = .015), distal involvement in ulcerative colitis (P = .014), and thoughts about the disease would last too soon in Crohn’s disease (odds ratio = 4.17, P = .049) were risk factors for non-adherence to treatment. Conclusion: The negative perception of treatment in inflammatory bowel disease affects adherence to the treatment. Considering some social factors that affect adherence to the treatment and taking measures to enhance the adherence to treatment will increase the success of treatment.

[1]  Shurong Hu,et al.  Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients , 2020, Patient preference and adherence.

[2]  M. Chaparro,et al.  Survey of adherence to treatment in inflammatory bowel disease. ENADEII study. , 2020, Gastroenterologia y hepatologia.

[3]  M. Chaparro,et al.  Survey of adherence to treatment in inflammatory bowel disease. ENADEII study. , 2020, Gastroenterology & hepatology.

[4]  L. Stassen,et al.  ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. , 2019, Journal of Crohn's & colitis.

[5]  R. Leong,et al.  Medication non-adherence in inflammatory bowel diseases is associated with disability , 2018, Intestinal research.

[6]  J. Drabek,et al.  Adherence, risk factors of non-adherence and patient’s preferred treatment strategy of mesalazine in ulcerative colitis: multicentric observational study , 2018, Scandinavian journal of gastroenterology.

[7]  L. Peyrin-Biroulet,et al.  Colorectal cancer prevention in patients with ulcerative colitis. , 2018, Best practice & research. Clinical gastroenterology.

[8]  T. Molnár,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. , 2017, Journal of Crohn's & colitis.

[9]  Eun Soo Kim,et al.  Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea , 2016, Journal of gastroenterology and hepatology.

[10]  S. Kane,et al.  Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies , 2015, Inflammatory bowel diseases.

[11]  M. Hankins,et al.  Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse , 2013, Alimentary pharmacology & therapeutics.

[12]  A. Kornbluth,et al.  Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence , 2011, Inflammatory bowel diseases.

[13]  R. Horne,et al.  Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic Review , 2010, The American Journal of Gastroenterology.

[14]  R. Horne,et al.  Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[15]  Mahendra Patel,et al.  Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence , 2009 .

[16]  G. Rubin,et al.  Review article: medication non‐adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies , 2008, Alimentary pharmacology & therapeutics.

[17]  K. Mazzocco,et al.  Risk factors for non‐adherence to medication in inflammatory bowel disease patients , 2007, Alimentary pharmacology & therapeutics.

[18]  A. Kuběna,et al.  Non-adherence to treatment in inflammatory bowel disease in Czech Republic. , 2007, Journal of Crohn's & colitis.

[19]  A. Thomson Patient nonadherence to medication in inflammatory bowel disease. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[20]  John Weinman,et al.  Self-regulation and Self-management in Asthma: Exploring The Role of Illness Perceptions and Treatment Beliefs in Explaining Non-adherence to Preventer Medication , 2002 .

[21]  F. Casellas,et al.  Influence of inflammatory bowel disease on different dimensions of quality of life , 2001, European journal of gastroenterology & hepatology.

[22]  R. Levy,et al.  Increasing patient adherence to gastroenterology treatment and prevention regimens , 1999, American Journal of Gastroenterology.

[23]  J. Weinman,et al.  The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .

[24]  I. Leodolter [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.

[25]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.